Top Markets
Coin of the day
HK inno.N Corporation HK inno.N Corporation

HK inno.N Corporation

195940
株式のランク #10328
Founded in 1984 and headquartered in Cheongju-si, South Korea, HK inno.N... Founded in 1984 and headquartered in Cheongju-si, South Korea, HK inno.N Corporation operates as a pharmaceutical enterprise. The company boasts a comprehensive portfolio of prescription medications designed to address a wide array of medical conditions. These include treatments for various infectious diseases, such as those caused by gram-positive and gram-negative bacteria, vancomycin-resistant Enterococcus faecium, acute bacterial sinusitis, bronchitis, and pneumonia. Their therapeutic offerings also extend to chronic illnesses like anemia, diabetes, hypertension (including cases with dyslipidemia), and hypercholesterolemia (covering primary and homozygous familial types), alongside solutions for hemodialysis. The firm develops drugs for gastrointestinal disorders such as GERD, EE, NERD, GU, and H. Pylori infections. In the oncology sector, HK inno.N provides treatments for non-small cell lung cancer, colorectal cancer, and both pleural and general mesothelioma. Additionally, they offer nutritional and intravenous therapeutic solutions. Beyond pharmaceuticals, the corporation supplies health and wellness products, including hangover relief drinks, ready-to-drink beverages, health supplements, functional foods, and active pharmaceutical ingredients. Its beauty division markets products under the bewants, ScalpMed, and KLEDERMA RX brands. The company maintains an international presence, exporting its diverse range of products to markets across Japan, Southeast Asia, Latin America, Europe, and the Middle East.
株価
$30.18
最終同期: 2026-08-28
時価総額
$855.10M
変化(1日)
1.39%
変化(1年)
-12.84%
KR
取引 HK inno.N Corporation (195940)

カテゴリー

HK inno.N Corporation(195940)の利益
2026 時点の利益 TTM: 0
HK inno.N Corporation の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
HK inno.N Corporation の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。